Data gathered: November 27
AI Stock Analysis - Charles River Laboratories (CRL)
Analysis generated August 19, 2024. Powered by Chat GPT.
Charles River Laboratories International, Inc. (NYSE: CRL) is a global provider of essential products and services to expedite the discovery, early-stage development, and safe manufacture of novel drugs and therapeutics. They operate through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (MS). With an extensive portfolio of services, Charles River Laboratories aims to enhance the productivity and efficiency of pharmaceutical and biotechnology companies, government agencies, and leading academic institutions worldwide.
Stock Alerts - Charles River Laboratories (CRL)
 |
Charles River Laboratories | November 17 AI Score is down by 20.3% in the last couple of days. |
|
Charles River Laboratories | November 15 Price is down by -5.5% in the last 24h. |
|
Charles River Laboratories | November 12 Employee Rating is down by 3% over the last month. |
|
Charles River Laboratories | November 6 Price is up by 21.5% in the last 24h. |
Alternative Data for Charles River Laboratories
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 358 | Sign up | Sign up | Sign up |
| Sentiment | 58 | Sign up | Sign up | Sign up |
| Webpage traffic | 232,000 | Sign up | Sign up | Sign up |
| Employee Rating | 64 | Sign up | Sign up | Sign up |
| Google Trends | 16 | Sign up | Sign up | Sign up |
| Patents | 6 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 789 | Sign up | Sign up | Sign up |
| Facebook Followers | 22,134 | Sign up | Sign up | Sign up |
| Instagram Followers | 5,206 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 867 | Sign up | Sign up | Sign up |
| Twitter Followers | 9,383 | Sign up | Sign up | Sign up |
| Twitter Mentions | 17 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 4,060 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 33 | Sign up | Sign up | Sign up |
| Linkedin Employees | 14,796 | Sign up | Sign up | Sign up |
About Charles River Laboratories
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment and Manufacturing Support.
| Price | $199.59 |
| Target Price | Sign up |
| Volume | 145,190 |
| Market Cap | $10.3B |
| Year Range | $178.58 - $273.43 |
| Dividend Yield | 0% |
| PE Ratio | 25.13 |
| Analyst Rating | 8% buy |
| Industry | Biotechnology |
In the news
 |
Charles Schwab Investment Management Inc. Purchases 32,311 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)November 27 - ETF Daily News |
|
Commerce Bank Reduces Stake in Charles River Laboratories International, Inc. (NYSE:CRL)November 25 - ETF Daily News |
|
Natixis Advisors LLC Lowers Stake in Charles River Laboratories International, Inc. (NYSE:CRL)November 20 - ETF Daily News |
|
Kentucky Retirement Systems Insurance Trust Fund Decreases Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)November 20 - ETF Daily News |
|
CIBC Asset Management Inc Raises Position in Charles River Laboratories International, Inc. (NYSE:CRL)November 20 - ETF Daily News |
|
Apollon Wealth Management LLC Makes New Investment in Charles River Laboratories International, Inc. (NYSE:CRL)November 19 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 1.03B | 923M | 103M | 70M | 150M | 2.590 |
| Q2 '24 | 1.04B | 892M | 150M | 94M | 184M | 2.800 |
| Q1 '24 | 998M | 908M | 90M | 73M | 165M | 2.270 |
| Q4 '23 | 1B | 261M | 743M | 187M | 277M | 2.460 |
| Q3 '23 | 1.02B | 225M | 790M | 87M | 180M | 2.720 |
Insider Transactions View All
| LaPlume Joseph W filed to sell 22,521 shares at $199.4. August 12 '24 |
| FOSTER JAMES C filed to sell 188,251 shares at $250. August 5 '24 |
| MASSARO GEORGE filed to sell 5,855 shares at $236.8. May 16 '24 |
| MASSARO GEORGE filed to sell 5,951 shares at $235.6. May 16 '24 |
| MASSARO GEORGE filed to sell 6,064 shares at $234.7. May 16 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rohit Khanna Democrat |
Jun 5, 24 | Sell | $1K - $15K |
| Rohit Khanna Democrat |
Nov 8, 23 | Buy | $1K - $15K |
| Lois Frankel Democrat |
Oct 10, 23 | Sell | $1K - $15K |
Read more about Charles River Laboratories (CRL) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Charles River Laboratories?
The Market Cap of Charles River Laboratories is $10.3B.
What is Charles River Laboratories' PE Ratio?
As of today, Charles River Laboratories' PE (Price to Earnings) ratio is 25.13.
What is the current stock price of Charles River Laboratories?
Currently, the price of one share of Charles River Laboratories stock is $199.59.
How can I analyze the CRL stock price chart for investment decisions?
The CRL stock price chart above provides a comprehensive visual representation of Charles River Laboratories' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Charles River Laboratories shares. Our platform offers an up-to-date CRL stock price chart, along with technical data analysis and alternative data insights.
Does CRL offer dividends to its shareholders?
As of our latest update, Charles River Laboratories (CRL) does not offer dividends to its shareholders. Investors interested in Charles River Laboratories should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Charles River Laboratories?
Some of the similar stocks of Charles River Laboratories are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.